Open AccessPleuroparenchymal fibroelastosis (PPFE) treated with lung transplantation and review of the literature
Author(s) -
Muhammad Ali,
Vijaya Sivalingam Ramalingam,
George B. Haasler,
Kenneth W. Presberg
Publication year - 2019
Publication title -
bmj case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.231
H-Index - 26
ISSN - 1757-790X
DOI - 10.1136/bcr-2019-229402
Subject(s) - medicine , lung transplantation , lung , parenchyma , histopathology , lung biopsy , transplantation , bronchiectasis , radiology , biopsy , interstitial lung disease , pulmonary fibrosis , cardiothoracic surgery , idiopathic pulmonary fibrosis , fibrosis , surgery , pathology
A 26-year-old woman presented with a 15-year history of non-progressive dyspnoea. Chest imaging showed bilateral apical pleural and parenchymal scarring, pleural thickening and bronchiectasis. Pulmonary function tests showed a moderate restrictive defect. Non-invasive workup was non-revealing; therefore, the patient was referred for video-assisted thoracic surgery and lung biopsy. Histopathology revealed pleural thickening and, subpleural parenchymal fibrosis and elastic tissue deposition. Lung parenchyma further away from the pleura was well preserved. Based on these findings, the patient was diagnosed with pleuroparenchymal fibroelastosis (PPFE). Since PPFE is a progressive disorder without effective medical therapies, and given our patient's worsening symptoms, she underwent bilateral lung transplantation. It has been almost 4 years since the lung transplantation, our patient continues to do well. To the best of our knowledge, to date, this is the longest follow-up reported for a PPFE patient undergoing lung transplantation.